Overcoming chemoresistance in non-angiogenic colorectal cancer by metformin via inhibiting endothelial apoptosis and vascular immaturity

Guangyue Li(First Affiliated Hospital of Xi'an Jiaotong University), Jichang Wang(First Affiliated Hospital of Xi'an Jiaotong University)

Journal of Pharmaceutical Analysis

February 9, 2023

10.1016/j.jpha.2023.02.001

Cited by 12

Related Papers

Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation

|Journal of Experimental & Clinical Cancer Research|2019|141

Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis

|Oncotarget|2015|107

Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China

|Experimental and Therapeutic Medicine|2017|12